Bacterial cell metabolism and surface structures

This target category encompasses the fundamental biochemical pathways and structural components essential for the survival, growth, and pathogenesis of bacterial cells. It includes the peptidoglycan cell wall, which provides osmotic stability and structural integrity, and the cytoplasmic membrane, which regulates nutrient transport and energy transduction (StatPearls, 2023). Additionally, it covers core metabolic machinery such as the bacterial 70S ribosome for protein synthesis and DNA gyrase/topoisomerase IV for genetic replication and transcription (Merck Manual, 2022). Antibacterial drugs exploit the evolutionary differences between prokaryotic and eukaryotic cells to achieve selective toxicity, targeting features absent or significantly different in humans. For example, beta-lactams and glycopeptides inhibit cell wall assembly, while macrolides and tetracyclines interfere with ribosomal function (NCBI Bookshelf, 2021). Because this classification represents a broad set of molecular targets rather than a single entity, it is often used in pharmacological databases to describe the collective site of action for antibiotics or to categorize drugs with pleiotropic effects on bacterial physiology. The primary therapeutic challenge associated with these targets is the rapid emergence of multi-drug resistance and the collateral damage to the host's protective microbiome.

Other names

Bacterial cells – general metabolism and cell surface structuresBacterial targetsAntibiotic targetsProkaryotic metabolic and structural targets

Inhibition of essential bacterial processes including cell wall peptidoglycan synthesis, protein translation at the 70S ribosome, DNA replication via topoisomerases, and metabolic pathways such as folate biosynthesis.